NovioSense's glucose sensor.
A new joint venture made up of two American and two European companies will aim to use near-field communication (NFC) technology to create new options for diabetes management. The Mayo Clinic and Washington, DC-based medical technology company Gentag will form the American half of the venture, while Dutch medical technology company NovioSense and German R&D...
